YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma

Phase 2

Recruiting

Conditions: Endometrial Carcinoma

Interventions: Drug: Sacituzumab Govitecan

First Posted Date: 2020-01-31

Last Posted Date: 2025-01-09

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT04251416

Locations: 🇺🇸
Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, United States

Measuring the Neuroimmune Response to Alcohol

Early Phase 1

Completed

Conditions: Alcohol Drinking

Interventions: Drug: Oral Alcohol Challenge

First Posted Date: 2020-01-31

Last Posted Date: 2023-11-07

Lead Sponsor: Yale University

Target Recruit Count: 14

Registration Number: NCT04251221

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Switching to Potential Reduced Exposure Products in Adult Smokers

Not Applicable

Completed

Conditions: Harm Reduction
Toxic Effect of Tobacco and Nicotine
Tobacco Use Disorder
Oral Nicotine Pouch Use
Smoking Behaviors
Carcinogenesis

Interventions: Device: ZYN

First Posted Date: 2020-01-31

Last Posted Date: 2024-05-01

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT04250727

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Treatment of Pregnant Women With OUD

Not Applicable

Completed

Conditions: Opioid-use Disorder

Interventions: Behavioral: Collaborative Care (CC)
Behavioral: Extension for Community Healthcare Outcomes (ECHO)

First Posted Date: 2020-01-27

Last Posted Date: 2025-05-21

Lead Sponsor: Yale University

Target Recruit Count: 230

Registration Number: NCT04240392

Locations: 🇺🇸
Hospital of Central CT, New Britain, Connecticut, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

and more 8 locations

Transcranial Magnetic Stimulation on Neural and Behavioral Facets of Social Cognition in Autism Spectrum Disorder

Not Applicable

Active, not recruiting

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Transcranial Magnetic Stimulation (TMS)

First Posted Date: 2020-01-27

Last Posted Date: 2024-04-23

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT04242355

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System

Recruiting

Conditions: Heart Failure
Heart Failure With Preserved Ejection Fraction
Heart Failure NYHA Class IV
Heart Failure With Reduced Ejection Fraction

First Posted Date: 2020-01-23

Last Posted Date: 2025-03-04

Lead Sponsor: Yale University

Target Recruit Count: 40000

Registration Number: NCT04237701

Locations: 🇺🇸
Yale New Haven Health System, New Haven, Connecticut, United States

Imaging the Neuroimmune System in PTSD

Phase 1

Completed

Conditions: Post Traumatic Stress Disorder

Interventions: Drug: Lipopolysaccharide

First Posted Date: 2020-01-22

Last Posted Date: 2024-12-09

Lead Sponsor: Yale University

Target Recruit Count: 80

Registration Number: NCT04236986

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Voiding Diary Video

Not Applicable

Completed

Conditions: Urinary Incontinence

Interventions: Other: 5-minute educational video
Other: Usual Care

First Posted Date: 2020-01-18

Last Posted Date: 2022-06-10

Lead Sponsor: Yale University

Target Recruit Count: 86

Registration Number: NCT04233645

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Neuroimmune Response to Lipopolysaccharide

Phase 1

Completed

Conditions: Healthy

Interventions: Biological: Lipopolysaccharide

First Posted Date: 2020-01-18

Last Posted Date: 2022-07-19

Lead Sponsor: Yale University

Target Recruit Count: 27

Registration Number: NCT04233593

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Emergency Department-Initiated Buprenorphine Validation Network Trial

Phase 2

Completed

Conditions: Opioid-use Disorder

Interventions: Drug: CAM2038
Drug: Buprenorphine Sublingual Product

First Posted Date: 2020-01-13

Last Posted Date: 2025-01-10

Lead Sponsor: Yale University

Target Recruit Count: 2000

Registration Number: NCT04225598

Locations: 🇺🇸
Highland Hospital, Oakland, California, United States
🇺🇸
San Leandro Hospital, San Leandro, California, United States
🇺🇸
Yale New Haven Health (Yale New Haven Hospital), New Haven, Connecticut, United States

and more 32 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy